ClinicalTrials.Veeva

Menu

Para Aortic Lymphadenectomy : Always ? (PALA)

University Hospital Center (CHU) logo

University Hospital Center (CHU)

Status

Completed

Conditions

Cervical Cancer

Treatments

Procedure: Para Aortic Lymphadenectomy (PAL) by laparoscopy

Study type

Observational

Funder types

Other

Identifiers

NCT04392895
RECHMPL20_0296

Details and patient eligibility

About

Cervical cancer affects more than 3000 new cases per year in France. The treatment of stage IB3 to IVA cervical cancer is based on concomitant radio-chemotherapy. The irradiation volumes are based, according to current recommendations, on imaging examinations and / or on the results of a laparoscopic Para-aortic lymphadenectomy (PAL). There is some risk of false negatif with the PET/CT. For this reason, most of the time, PAL is offered when there is no pathological paraaortic lymph node on PET/CT. The investigators suppose that this staging surgery could be avoid when no pathological pelvic nodes are identified on PET/CT. The investigators use a retrospective study, to analyse histological report of systematic PAL, comparing to results of pre-operative PET/CT.

Enrollment

160 patients

Sex

Female

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients with :
  • locally advanced cervical cancer,
  • who undergone PAL
  • with pre operative PET CT, between January 2015 and december 2019

Exclusion criteria

  • patients aged under 18

Trial design

160 participants in 1 patient group

Patients with locally advanced cervical cancer
Description:
Patients with locally advanced cervical cancer, who had undergone a PAL
Treatment:
Procedure: Para Aortic Lymphadenectomy (PAL) by laparoscopy

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems